How Collateralized Fund Obligations Are Reshaping Insurance Capital

Collateralized fund obligations have quietly become one of the fastest-growing pathways for insurance capital to reach private equity, and a $1.5 billion deal from Franklin Templeton just made that shift impossible to ignore. For credit research, PE/VC, and structured finance teams, understanding how these structures allocate risk matters more than the headline deal size.

---

Key Takeaways

Collateralized fund obligations let insurance companies gain private equity exposure through rated debt tranches, but their cash flows depend on irregular PE exits that can stall together when markets weaken.

• Franklin Templeton closed a $1.5 billion collateralized fund obligation in August 2026, its first CFO.

• The structure lets insurance companies access private equity through senior, investment-grade-rated tranches.

• Cash flows depend on irregular PE exits, sales, refinancings, and IPOs, unlike conventional loan collateral.

• The NAIC has been tightening risk-based capital scrutiny of CFOs and similar structures throughout 2026.

What Franklin Templeton’s $1.5 Billion CFO Signals

A $1.5 billion deal just signaled how far insurance capital has moved into private equity, and few outside credit desks have noticed. Franklin Templeton recently closed its inaugural collateralized fund obligation, Structured Solutions 2026, raising $1.5 billion from global investors.

The transaction packaged a diversified pool of private equity fund stakes and continuation-fund positions managed by Lexington Partners, alongside middle-market loans from Benefit Street Partners, into tranches of rated debt. Insurance capital flowing toward alternative assets follows a similar logic, a pattern already examined in how insurers are financing AI infrastructure.

This is not an isolated transaction. Several of the largest secondaries managers have pursued similar structures over the past year, turning CFOs into a mainstream fundraising tool rather than a niche instrument.

The mechanics behind that shift deserve closer attention than the headline number alone provides.

How Insurance Capital Accesses Private Equity Now

The structure matters because it opens a regulated pathway for insurance companies, typically restricted from holding private equity directly, to gain exposure through senior, investment-grade-rated tranches while equity holders absorb losses first.

Firms within BFSI have long faced capital-charge constraints on direct private equity holdings, which made rated, tranche-based exposure an attractive workaround. Consequently, demand for CFOs has grown fastest among precisely the investor base historically locked out of the asset class.

Evaluating these tranches requires the same rigor applied to any structured credit instrument. A well-resourced credit research function needs to look through the rating to the underlying collateral quality, not just the assigned grade.

Access alone does not guarantee suitability. The rating provides comfort, but comfort is not the same as understanding what backs it.

Why CFO Cash Flows Carry Hidden Risk

The underlying risk deserves equal attention. Unlike conventional loans, cash flows depend on private equity exits, sales, refinancings, and IPOs, that occur irregularly and can stall for extended periods in weak markets.

Diversification protects senior holders only if those exit events remain uncorrelated, an assumption that weakens precisely when markets turn. This dynamic echoes broader liquidity pressures already documented in a recent look at the 2026 private equity liquidity crisis.

Sponsor-level financing behavior offers an early warning signal here too. Shifting lender appetite at the GP level, covered in recent analysis of what GP financing trends signal for private equity’s future, tends to move in tandem with the exit-timing pressures CFO structures depend on.

A rated tranche can insulate against moderate stress. It offers far less protection when exit markets seize up broadly, rather than selectively.

What Regulators Are Watching In CFO Structures

Regulators have already begun signaling closer scrutiny of these structures, a trend worth watching as issuance accelerates. The NAIC has spent much of 2026 tightening risk-based capital treatment of collateralized loan obligations and related structured vehicles.

That scrutiny extends specifically to structures like CFOs, where regulators have pushed for look-through analysis to ensure fund-backed debt does not receive more favorable capital treatment than the underlying private equity would receive if held directly.

For PE/VC support teams advising sponsors on secondaries fundraising, this regulatory direction matters as much as current investor demand. Structures built around today’s capital treatment may face materially different economics once new rules take effect.

Issuance is accelerating for now. Whether the regulatory framework catches up before or after the next liquidity stress event remains an open question.

FAQ

When did collateralized fund obligations start attracting mainstream insurance demand?

Collateralized fund obligations moved from a niche instrument to a mainstream fundraising tool over the past year, with several of the largest secondaries managers pursuing similar structures before Franklin Templeton’s $1.5 billion CFO closed in August 2026. (Source: PitchBook)

Can senior CFO tranches fully insulate insurance holders from private equity risk?

Senior tranches are structured so equity holders absorb losses first, which provides meaningful protection in moderate stress scenarios; however, diversification benefits weaken specifically when private equity exit events become correlated across the portfolio during broad market downturns.

Who is most exposed if private equity exit markets stall broadly?

Insurance companies and other senior-tranche holders face the most exposure if exits stall broadly, since their protection depends on uncorrelated timing across the underlying private equity positions, an assumption that breaks down precisely when markets turn.

Is a higher credit rating on a CFO tranche the same as lower risk?

Not entirely. A rating reflects tranche seniority and modeled loss expectations, but regulators including the NAIC have pushed for look-through analysis specifically because a favorable rating can mask underlying collateral risk that wouldn’t receive the same capital treatment if held directly. (Source: Clifford Chance)